Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through the Vitamin D Pathway

NCT01499940 is registered in ClinicalTrials.gov with Gerald Higa, PharmD. as lead sponsor.

NCT NCT01499940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through the Vitamin D Pathway
Lead sponsor
Gerald Higa, PharmD.
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2012
Completion date
December 31, 2012
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurotoxicity